News

Alirocumab meets primary endpoints in ODYSSEY CHOICE trials

14.01.20152205

Sanofi and Regeneron Pharmaceuticals Inc. announced that the phase 3 ODYSSEY CHOICE I and CHOICE II trials had each met their primary efficacy endpoints for monthly treatment with alirocumab in patients with hypercholesterolemia.

Right heart dysfunction in heart failure with preserved ejection fraction

13.01.20151991

The goal of this study was to examine the haemodynamic, clinical, and prognostic correlates of right ventricular dysfunction (RVD) in HFpEF.

Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint

12.01.20151774

What is the long-term success rate of a stepwise radiofrequency catheter ablation strategy for persistent atrial fibrillation (AF)?

Digoxin linked to elevated risk for death, hospitalization in patients with AF

30.12.20141860

Data from the ATRIA-CVRN study suggest an association between digoxin and increased risk for death and hospitalization in patients with atrial fibrillation.

Russian Society of Cardiology gives 15 grants for participation in the Congress of the European Society of Cardiology 2015

29.12.20142873

Grants are provided for those young specialists whose abstracts will be accepted as oral or poster presentation.

Chairperson of the Working Group of Young Cardiologists is elected! Take part in it!

29.12.20142603

We founded Working Group of Young Cardiologist in 2009, and all these years we did our best to provide young cardiologists of RSC with opportunities to develop in Russia and abroad.

Statin use linked to risk for cataracts

29.12.20141662

Patients treated with statins for CVD prevention were more likely than nonusers to develop cataracts requiring surgical treatment, researchers reported in the Canadian Journal of Cardiology.